NASH Accelerated Approval: US FDA Remains Confident In Pathway For Liver Disease
• By Michael McCaughan
NASH (non-alcoholic steatohepatitis) is now also known as MASH (metabolic dysfunction associated steatohepatitis). • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
